perfosfamide has been researched along with Leukemia in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (48.00) | 18.7374 |
| 1990's | 9 (36.00) | 18.2507 |
| 2000's | 1 (4.00) | 29.6817 |
| 2010's | 3 (12.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blicharski, K; Fedoročko, P; Mazur, L; Mikeš, J; Niemeyer, U; Opydo-Chanek, M; Śladowska, K | 1 |
| Shibayama, Y; Sugawara, M; Takada, K; Takekuma, Y; Tazawa, Y; Usukubo, I | 1 |
| Ambinder, RF; Blackford, AL; Davis-Sproul, JM; Gocke, CD; Gore, SD; Jones, RJ; Kasamon, YL; Seifter, EJ | 1 |
| Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Kobayashi, H; Mano, H; Tsunoda, S | 1 |
| Colvin, MO; Hess, AD; Kaizer, H; Körbling, M; Santos, GW; Tutschka, PJ | 1 |
| Braine, H; Colvin, M; Kaizer, H; Korbling, M; Santos, G; Saral, R; Stuart, R; Tutschka, P | 1 |
| Douay, L; Giarratana, MC; Gorin, NC; Hu, C | 1 |
| Ball, ED; Malley, V; Rubin, J | 1 |
| Rosenfeld, CS | 1 |
| Jones, RJ | 1 |
| Clarkson, BD; Gulati, SC; Haley, JD; Lemoli, RM; Strife, A | 1 |
| Jollow, DJ; Peters, RH; Stuart, RK | 1 |
| Kaizer, H; Rowley, SD; Santos, GW; Yeager, AM | 1 |
| Peters, RH; Stuart, RK | 1 |
| Moreb, J; Rueth, S; Zucali, JR | 1 |
| Colvin, OM; Santos, GW | 1 |
| Konno, T; Minegishi, M; Minegishi, N; Tsuchiya, S | 1 |
| Gorin, NC | 1 |
| Flesch, M; Hervé, P | 1 |
| Andersson, BS; Beran, M; Farquhar, D; McCredie, KB; Wang, Y | 1 |
| Braine, HG; Colvin, OM; Davis, J; Jones, RJ; Rowley, SD; Santos, GW; Saral, R; Sensenbrenner, LL; Yeager, A; Zuehlsdorf, M | 1 |
| Debusscher, L; Delforge, A; Loos, M; Rongé-Collard, E; Socquet, M; Stryckmans, P | 1 |
| Beschorner, WE; Braine, HG; Brookmeyer, R; Burns, WH; Fuller, DJ; Kaizer, H; Korbling, M; Mangan, KF; Saral, R; Stuart, RK | 1 |
| Douay, L | 1 |
| Goldman, JM; Gordon, MY; Gordon-Smith, EC | 1 |
3 review(s) available for perfosfamide and Leukemia
| Article | Year |
|---|---|
Purging with 4-hydroperoxycyclophosphamide.
Topics: Acute Disease; Bone Marrow Purging; Bone Marrow Transplantation; Clinical Trials as Topic; Cyclophosphamide; Humans; Leukemia; Lymphoma | 1992 |
Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Busulfan; Child; Cyclophosphamide; Humans; Leukemia; Neoplastic Stem Cells; Remission Induction; Transplantation, Autologous; Whole-Body Irradiation | 1990 |
Pharmacological purging of bone marrow with reference to autografting.
Topics: Adolescent; Adult; Animals; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Cell Separation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lysophosphatidylcholines; Methylprednisolone; Neoplasms, Experimental; Phospholipid Ethers; Pyrimidinones; Transplantation, Autologous; Transplantation, Isogeneic | 1986 |
3 trial(s) available for perfosfamide and Leukemia
| Article | Year |
|---|---|
Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas.
Topics: Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cell Transformation, Neoplastic; Cyclophosphamide; Female; Follow-Up Studies; Humans; Leukemia; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous | 2011 |
Pharmacological purging of bone marrow with reference to autografting.
Topics: Adolescent; Adult; Animals; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Cell Separation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lysophosphatidylcholines; Methylprednisolone; Neoplasms, Experimental; Phospholipid Ethers; Pyrimidinones; Transplantation, Autologous; Transplantation, Isogeneic | 1986 |
Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; In Vitro Techniques; Leukemia; Leukopenia; Male; Middle Aged; Postoperative Complications; Transplantation, Autologous | 1985 |
20 other study(ies) available for perfosfamide and Leukemia
| Article | Year |
|---|---|
Comparison of
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Membrane; Cell Survival; Cyclophosphamide; Esterases; Gene Expression Regulation, Neoplastic; Humans; Ifosfamide; Leukemia; Membrane Potential, Mitochondrial | 2017 |
Schedule-dependent cytotoxicity of Etoposide and cyclophosphamide in P-glycoprotein-expressing human leukemic K-562 cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Cycle; Cell Survival; Cyclophosphamide; Drug Administration Schedule; Etoposide; Humans; K562 Cells; Leukemia | 2014 |
Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Camptothecin; Carboplatin; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Cytarabine; Depsipeptides; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Imatinib Mesylate; Irinotecan; K562 Cells; Leukemia; Lymphoma; Mercaptopurine; Piperazines; Pyrimidines; Time Factors | 2007 |
4-hydroperoxycyclophosphamide: a model for eliminating residual human tumour cells and T-lymphocytes from the bone marrow graft.
Topics: Bone Marrow Transplantation; Cells, Cultured; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Leukemia; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; T-Lymphocytes; Transplantation, Autologous | 1982 |
Autologous bone marrow transplantation in acute leukemia and non-Hodgkin's lymphoma: a phase I study of 4-hydroperoxycyclophosphamide (4HC) incubation of marrow prior to cryopreservation.
Topics: Acute Disease; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Drug Evaluation; Freezing; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Tissue Preservation | 1983 |
Amifostine (WR-2721) protects normal haematopoietic stem cells against cyclophosphamide derivatives' toxicity without compromising their antileukaemic effects.
Topics: Amifostine; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Leukemia; Neoplastic Stem Cells | 1995 |
A combination of anti-CD15 monoclonal antibody PM-81 and 4-hydroperoxycyclophosphamide augments tumor cytotoxicity while sparing normal progenitor cells.
Topics: Acute Disease; Antibodies, Monoclonal; Bone Marrow Purging; Combined Modality Therapy; Cyclophosphamide; Cytotoxicity, Immunologic; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myeloid; Leukocytes, Mononuclear; Lewis X Antigen; Tumor Cells, Cultured | 1994 |
Antileukemic activity of phenylalanine methyl ester (PME): a lysosomotropic peptide methyl ester.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blast Crisis; Child; Cyclophosphamide; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Monocytes; Phenylalanine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temperature; Tumor Cells, Cultured | 1994 |
TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro.
Topics: Bone Marrow Cells; Bone Marrow Purging; Cell Survival; Cyclophosphamide; Erythroid Precursor Cells; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Macrophages; Transforming Growth Factor beta; Tumor Cells, Cultured | 1992 |
Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
Topics: Animals; Antineoplastic Agents; Buthionine Sulfoximine; Cell Line; Cell Survival; Cisplatin; Cyclophosphamide; Drug Screening Assays, Antitumor; Drug Synergism; Glutathione; Humans; Kinetics; Leukemia; Leukemia, Experimental; Methionine Sulfoximine | 1991 |
Synergism between 4-hydroperoxycyclophosphamide and cisplatin: importance of incubation sequence and measurement of cisplatin accumulation.
Topics: Cell Survival; Cisplatin; Cyclophosphamide; Drug Synergism; Humans; Leukemia; Platinum; Spectrophotometry, Atomic; Tumor Cells, Cultured | 1990 |
The effects of tumor necrosis factor-alpha on early human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide.
Topics: Cell Line; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Interleukin-1; Leukemia; Tumor Necrosis Factor-alpha | 1990 |
Effects of in vitro treatment with 4-hydroperoxycyclophosphamide and hyperthermia on leukemic progenitor cells.
Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Female; Fever; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Infant; Leukemia; Male; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Autologous bone marrow transplantation in acute leukemia.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Bone Marrow Transplantation; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Leukemia; Magnetics; Neprilysin; Rabbits; Recurrence; Ricin; Transplantation, Autologous; Whole-Body Irradiation | 1986 |
[Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies].
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cell Separation; Centrifugation, Density Gradient; Cyclophosphamide; Graft vs Host Disease; Humans; Lectins; Leukemia; Lymphocyte Depletion; Methylprednisolone; Neoplasms; Neprilysin; Pilot Projects; Plant Lectins; Ricin; Soybean Proteins; T-Lymphocytes; Transplantation, Autologous; Transplantation, Homologous | 1986 |
The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging.
Topics: Bone Marrow; Bone Marrow Transplantation; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Leukemia; Neoplastic Stem Cells; Phosphoramide Mustards; Regeneration | 1988 |
CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow.
Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Child; Child, Preschool; Colony-Forming Units Assay; Cyclophosphamide; Female; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia; Leukocyte Count; Macrophages; Male; Middle Aged; Platelet Count; Transplantation, Autologous | 1987 |
Effect of 4-hydroperoxycyclophosphamide on leukemic and normal human myeloid progenitor cells.
Topics: Acute Disease; Bone Marrow; Cyclophosphamide; Dose-Response Relationship, Drug; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myeloid, Acute; Tumor Stem Cell Assay | 1985 |
Cyclophosphamide derivatives for in vitro cleansing of leukemic bone marrow.
Topics: Animals; Bone Marrow; Bone Marrow Transplantation; Burkitt Lymphoma; Cell Line; Cell Separation; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Experimental; Mice; Rats | 1985 |
4-Hydroperoxycyclophosphamide inhibits proliferation by human granulocyte-macrophage colony-forming cells (GM-CFC) but spares more primitive progenitor cells.
Topics: Anemia, Aplastic; Bone Marrow Cells; Cell Differentiation; Cell Division; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Drug Resistance; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia; Macrophages; Transplantation, Autologous | 1985 |